Invest in ME Research Research Policy
Our Research Ethos
Invest in ME Research (IiMER) has, as an objective, to make a change in how ME is perceived and treated in the media, by health departments and by healthcare professionals.
We aim to do this by concentrating our efforts on three main areas - funding for biomedical research into ME, education of healthcare professionals, the media and the public and lobbying for improvement in the treatment of people with ME and their families. We have no membership fees and try to offer as much as possible for free, or at cost price.
Our efforts are focused on setting up a UK examination and research facility (click here) which will provide proper examinations and diagnosis for ME patients and a coordinated strategy of biomedical research into ME in order to find treatment(s) and cure(s).
Together with an ever growing number of resourceful and dedicated supporters we are all working toward the goal of making a positive contribution to progress.
Our Research Strategy
Invest in ME Research supports high quality, biomedical research into myalgic encephalomyelitis (ME).
The following paragraphs detail our policy and procedures for applying for funding for such research. The charity welcomes applications for grants for projects of 6 months - 3 years duration.
Our priorities are steered by the unequivocal belief that ME is of organic origin and requiring a strategy of biomedical research with international collaboration.
Our Research Priorities
Medical research into:
- Research associated with Causality
- Translational biomedical research to provide effective treatments for ME
- Accurate and comprehensive diagnosis
- Improved education of healthcare professionals about the disease
- Telemedicine for use with and by ME patients and their physicians
- Raising awareness amongst the public, the media and academia